Tricia R. Serio

Dr. Tricia R. Serio

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2020 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
JVJanice Villali
Janice Villali
JDJason Dark
Jason Dark
TBTeal M. Brechtel
Teal M. Brechtel
FPFen Pei
Fen Pei
SSSuzanne Sindi
Suzanne Sindi
TSTricia R. Serio
Tricia R. Serio

30 October 2017 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
FPFen Pei
Fen Pei
SDSusanne DiSalvo
Susanne DiSalvo
SSSuzanne Sindi
Suzanne Sindi
TSTricia R. Serio
Tricia R. Serio
Prions adopt alternative, self-replicating protein conformations and thereby determine novel phenotypes that are often irreversible. Nevertheless, dominant-negative prion mutants can revert phenotypes associated with some conformations. These observations suggest that, while intervention is possible, distinct inhibitors must be developed to overcome the conformational plasticity of prions. To understand the basis of this specificity, we determined the impact of the G58D mutant of the Sup35 prion on three of its conformational variants, which form amyloids in S. cerevisiae. G58D had been previously proposed to have unique effects on these variants, but our studies suggest a common mechanism. All variants, including those reported to be resistant, are inhibited by G58D but at distinct doses. G58D lowers the kinetic stability of the associated amyloid, enhancing its fragmentation by molecular chaperones, promoting Sup35 resolubilization, and leading to amyloid clearance particularly in daughter cells. Reducing the availability or activity of the chaperone Hsp104, even transiently, reverses curing. Thus, the specificity of inhibition is determined by the sensitivity of variants to the mutant dosage rather than mode of action, challenging the view that a unique inhibitor must be developed to combat each variant. Prion proteins adopt alternative conformations and assemble into amyloid fibers, which have been associated with human disease. These fibers are highly stable and self-replicate, leading to their persistence and resulting in a set of progressive and often fatal disorders. Inhibitors have been shown to interfere with some conformations but not others, suggesting that distinct strategies must be developed to target each. However, we show here that a single dominant-negative mutant can inhibit multiple conformations of the same prion protein through the same pathway but at distinct doses. Thus, the basis of this specificity is sensitivity rather than resistance to the mechanism of inhibition, suggesting that common strategies may be used to target a range of prion conformations.

6 March 2018 in FEMS Yeast Research
Verified
Journal Article
Open access
PDF file
TSTricia R. Serio
Tricia R. Serio
Prions are conformationally flexible proteins capable of adopting a native state and a spectrum of alternative states associated with a change in the function of the protein. These alternative states are prone to assemble into amyloid aggregates, which provide a structure for self-replication and transmission of the underlying conformer and thereby the emergence of a new phenotype. Amyloid appearance is a rare event in vivo, regulated by both the aggregation propensity of prion proteins and their cellular environment. How these forces normally intersect to suppress amyloid appearance and the ways in which these restrictions can be bypassed to create protein-only phenotypes remain poorly understood. The most widely studied and perhaps most experimentally tractable system to explore the mechanisms regulating amyloid appearance is the [PIN+] prion of Saccharomyces cerevisiae. [PIN+] is required for the appearance of the amyloid state for both native yeast proteins and for human proteins expressed in yeast. These observations suggest that [PIN+] facilitates the bypass of amyloid regulatory mechanisms by other proteins in vivo. Several models of prion appearance are compatible with current observations, highlighting the complexity of the process and the questions that must be resolved to gain greater insight into the mechanisms regulating these events.

24 October 2017 in eLife
Verified
Journal Article
Open access
MSMichael D Schaller
Michael D Schaller
GMGary McDowell
Gary McDowell
APAndré Porter
André Porter
DSDorothy Shippen
Dorothy Shippen
KFKatherine L Friedman
Katherine L Friedman
WSWesley I Sundquist
Wesley I Sundquist
Numerous concerns have been raised about the sustainability of the biomedical research enterprise in the United States. Improving the postdoctoral training experience is seen as a priority in addressing these concerns, but even identifying who the postdocs are is made difficult by the multitude of different job titles they can carry. Here, we summarize the detrimental effects that current employment structures have on training, compensation and benefits for postdocs, and argue that academic research institutions should standardize the categorization and treatment of postdocs. We also present brief case studies of two institutions that have addressed these challenges and can provide models for other institutions attempting to enhance their postdoctoral workforces and improve the sustainability of the biomedical research enterprise.

27 July 2022 in Viruses
Verified
Journal Article
Open access
PDF file
WNWesley Reza Naeimi
Wesley Reza Naeimi
TSTricia R. Serio
Tricia R. Serio
The formation of amyloid fibers is associated with a diverse range of disease and phenotypic states. These amyloid fibers often assemble into multi-protofibril, high-order architectures in vivo and in vitro. Prion propagation in yeast, an amyloid-based process, represents an attractive model to explore the link between these aggregation states and the biological consequences of amyloid dynamics. Here, we integrate the current state of knowledge, highlight opportunities for further insight, and draw parallels to more complex systems in vitro. Evidence suggests that high-order fibril architectures are present ex vivo from disease relevant environments and under permissive conditions in vivo in yeast, including but not limited to those leading to prion formation or instability. The biological significance of these latter amyloid architectures or how they may be regulated is, however, complicated by inconsistent experimental conditions and analytical methods, although the Hsp70 chaperone Ssa1/2 is likely involved. Transition between assembly states could form a mechanistic basis to explain some confounding observations surrounding prion regulation but is limited by a lack of unified methodology to biophysically compare these assembly states. Future exciting experimental entryways may offer opportunities for further insight.

17 May 2022
Verified
Report
Closed access
ABAshley Blamey
Ashley Blamey
ANArie L. Nettles
Arie L. Nettles
KRKatie Raftery
Katie Raftery
LRLaura Rugless
Laura Rugless
TSTricia R. Serio
Tricia R. Serio
HVHima Vatti
Hima Vatti